Balance Sheet Boston Scientific Corporation

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 21:00:02 20/05/2026 BST			After hours 01:00:00
56.67 ^USD	-0.25%		57.05	+0.67%

05-19	Leerink Partners Adjusts Boston Scientific PT to $87 From $86, Maintains Outperform Rating	MT
05-19	Boston Scientific Catheter Says Trial Meets Safety, Effectiveness Goals	MT

7bc28e53ad6e8765718e3.VGM0P0Q5dywHOeuBV4I1boP9J5qFNWKcdktfvhTDZak.JVpnUCkAHn9pSrzCLrIMOcapH_jEXDL2JCQUxCOxBtFnAV5rPlg-Hn9Dug

Published financial data: BOSTON SCIENTIFIC CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	11.89B	12.68B	14.24B	16.75B	20.07B
Total Revenues	11.89B	12.68B	14.24B	16.75B	20.07B
Cost of Goods Sold, Total	3.65B	4B	4.39B	5.29B	6.27B
Gross Profit	8.24B	8.68B	9.85B	11.46B	13.81B
Selling General & Admin Expenses, Total	4.29B	4.52B	5.19B	5.98B	6.89B
R&D Expenses	1.2B	1.32B	1.41B	1.62B	2.05B
Amortization of Goodwill and Intangible Assets - (IS)	741M	803M	828M	856M	897M
Other Operating Expenses, Total	6.23B	6.65B	7.43B	8.46B	9.84B
Operating Income	2.01B	2.03B	2.42B	3B	3.97B
Interest Expense, Total	-341M	-470M	-265M	-305M	-349M
Interest And Investment Income	4M	10M	22M	107M	29M
Net Interest Expenses	-337M	-460M	-243M	-198M	-320M
Currency Exchange Gains (Loss)	-27M	-31M	-41M	-16M	-12M
Other Non Operating Income (Expenses)	-7M	-14M	-16M	-30M	-34M
EBT, Excl. Unusual Items	1.64B	1.53B	2.12B	2.76B	3.6B
Restructuring Charges	-191M	-24M	-69M	-16M	-101M
Merger & Related Restructuring Charges	-34M	-	-	-	-
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	250M	-1M	-59M	-79M	139M
Gain (Loss) On Sale Of Assets	78M	-22M	-	-	-
Asset Writedown	-370M	-132M	-58M	-386M	-46M
Legal Settlements	-430M	-173M	111M	-	-194M
Other Unusual Items	136M	-35M	-58M	5M	-18M
EBT, Incl. Unusual Items	1.08B	1.14B	1.98B	2.28B	3.38B
Income Tax Expense	36M	443M	393M	436M	493M
Earnings From Continuing Operations	1.04B	698M	1.59B	1.85B	2.89B
Net Income to Company	1.04B	698M	1.59B	1.85B	2.89B
Minority Interest	-	-	1M	8M	6M
Net Income - (IS)	1.04B	698M	1.59B	1.85B	2.9B
Preferred Dividend and Other Adjustments	55M	56M	22M	1M	-
Net Income to Common Incl Extra Items	986M	642M	1.57B	1.85B	2.9B
Net Income to Common Excl. Extra Items	986M	642M	1.57B	1.85B	2.9B
Per Share Items
Net EPS - Basic	0.69	0.45	1.08	1.26	1.96
Basic EPS - Continuing Operations	0.69	0.45	1.08	1.26	1.96
Basic Weighted Average Shares Outstanding	1.42B	1.43B	1.45B	1.47B	1.48B
Net EPS - Diluted	0.69	0.45	1.07	1.25	1.94
Diluted EPS - Continuing Operations	0.69	0.45	1.07	1.25	1.94
Diluted Weighted Average Shares Outstanding	1.43B	1.44B	1.46B	1.49B	1.49B
Normalized Basic EPS	0.72	0.67	0.91	1.18	1.53
Normalized Diluted EPS	0.71	0.66	0.9	1.17	1.51
Payout Ratio	5.28	7.88	1.76	-	-
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	3.1B	3.17B	3.61B	4.27B	5.34B
EBITA	2.75B	2.84B	3.24B	3.86B	4.87B
EBIT	2.01B	2.03B	2.42B	3B	3.97B
EBITDAR	3.19B	3.26B	3.71B	4.37B	5.46B
Effective Tax Rate - (Ratio)	3.34	38.83	19.81	19.11	14.56
Current Domestic Taxes	51M	70M	204M	341M	264M
Current Foreign Taxes	127M	381M	116M	184M	241M
Total Current Taxes	178M	451M	320M	525M	505M
Deferred Domestic Taxes	-259M	-124M	-104M	-183M	-119M
Deferred Foreign Taxes	117M	117M	176M	92M	107M
Total Deferred Taxes	-142M	-7M	72M	-91M	-12M
Normalized Net Income	1.02B	955M	1.32B	1.73B	2.26B
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	1.2B	1.32B	1.41B	1.62B	2.05B
Net Rental Expense, Total	90M	91M	96M	98M	117M
Imputed Operating Lease Interest Expense	25.66M	36.27M	21.52M	23M	28.16M
Imputed Operating Lease Depreciation	64.34M	54.73M	74.48M	75M	88.84M
Stock-Based Comp., COGS (Total)	11M	12M	12M	14M	16M
Stock-Based Comp., R&D Exp. (Total)	36M	41M	42M	46M	53M
Stock-Based Comp., SG&A Exp. (Total)	147M	167M	179M	206M	231M
Stock-Based Comp., Other (Total)	-	-	-	-	-1M
Total Stock-Based Compensation	194M	220M	233M	266M	299M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.92B	928M	865M	414M	1.96B
Total Cash And Short Term Investments	1.92B	928M	865M	414M	1.96B
Accounts Receivable, Total	1.78B	1.97B	2.23B	2.56B	2.93B
Other Receivables	-	-	-	-	-
Total Receivables	1.78B	1.97B	2.23B	2.56B	2.93B
Inventory	1.61B	1.87B	2.48B	2.81B	2.94B
Prepaid Expenses	-	-	-	-	-
Deferred Tax Assets Current	-	-	-	-	-
Restricted Cash	188M	149M	130M	111M	80M
Other Current Assets, Total	816M	846M	807M	1.03B	880M
Total Current Assets	6.32B	5.76B	6.51B	6.92B	8.79B
Gross Property Plant And Equipment	5.96B	6.11B	6.78B	7.28B	8.11B
Accumulated Depreciation	-3.27B	-3.28B	-3.48B	-3.53B	-3.61B
Net Property Plant And Equipment	2.69B	2.83B	3.3B	3.74B	4.5B
Long-term Investments	412M	407M	413M	556M	682M
Goodwill	11.99B	12.92B	14.39B	17.09B	18.28B
Other Intangibles, Total	6.24B	5.97B	6.03B	6.68B	7.02B
Deferred Tax Assets Long-Term	4.14B	3.94B	3.84B	3.66B	3.68B
Other Long-Term Assets, Total	448M	639M	650M	748M	720M
Total Assets	32.23B	32.47B	35.14B	39.4B	43.67B
Liabilities
Accounts Payable, Total	794M	862M	942M	960M	1.14B
Accrued Expenses, Total	1.88B	1.86B	2.14B	2.53B	3.2B
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	261M	20M	531M	1.78B	299M
Current Portion of Leases	71M	61M	76M	81M	90M
Current Income Taxes Payable	209M	232M	220M	268M	-
Unearned Revenue Current, Total	208M	220M	266M	306M	313M
Other Current Liabilities	848M	553M	762M	473M	392M
Total Current Liabilities	4.27B	3.8B	4.93B	6.4B	5.44B
Long-Term Debt	8.8B	8.91B	8.57B	8.84B	11.01B
Long-Term Leases	395M	352M	395M	527M	571M
Unearned Revenue Non Current	276M	289M	311M	329M	369M
Deferred Tax Liability Non Current	310M	144M	134M	155M	220M
Other Non Current Liabilities	1.55B	1.4B	1.27B	1.14B	1.59B
Total Liabilities	15.61B	14.9B	15.61B	17.39B	19.2B
Common Stock, Total	17M	17M	17M	17M	17M
Additional Paid In Capital	19.99B	20.29B	20.65B	21.06B	21.5B
Retained Earnings	-1.39B	-750M	819M	2.67B	5.57B
Treasury Stock	-2.25B	-2.25B	-2.25B	-2.25B	-2.25B
Comprehensive Income and Other	262M	268M	50M	275M	-609M
Total Common Equity	16.62B	17.57B	19.28B	21.77B	24.23B
Minority Interest	-	-	248M	233M	239M
Total Equity	16.62B	17.57B	19.53B	22B	24.47B
Total Liabilities And Equity	32.23B	32.47B	35.14B	39.4B	43.67B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.43B	1.43B	1.47B	1.48B	1.48B
ECS Total Common Shares Outstanding	1.43B	1.43B	1.47B	1.47B	1.48B
Book Value / Share	11.66	12.26	13.16	14.76	16.34
Tangible Book Value	-1.6B	-1.32B	-1.14B	-2B	-1.07B
Tangible Book Value Per Share	-1.12	-0.92	-0.78	-1.36	-0.72
Total Debt	9.52B	9.34B	9.57B	11.23B	11.97B
Net Debt	7.6B	8.42B	8.7B	10.81B	10.01B
Debt Equivalent of Unfunded Proj. Benefit Obligation	166M	106M	117M	127M	119M
Debt Equivalent Oper. Leases	720M	728M	768M	784M	936M
Minority Interest, Total (Incl. Fin. Div)	-	-	248M	233M	239M
Equity Method Investments, Total	259M	188M	219M	-	396M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	452M	548M	773M	819M	849M
Inventories - Work In Process, Total	128M	147M	174M	193M	246M
Inventories - Finished Goods, Total	1.03B	1.17B	1.54B	1.8B	1.85B
Land - (BS)	109M	137M	140M	144M	173M
Buildings, Total	1.34B	1.7B	1.84B	2.02B	2.48B
Machinery, Total	3.48B	3.3B	3.5B	3.63B	3.83B
Full Time Employees	41K	45K	48K	53K	59K
Accumulated Allowance for Doubtful Accounts (Supple)	108M	109M	110M	109M	132M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	1.04B	698M	1.59B	1.85B	2.9B
Depreciation & Amortization - CF	352M	333M	368M	413M	471M
Amortization of Goodwill and Intangible Assets - (CF)	741M	803M	828M	856M	897M
Depreciation & Amortization, Total	1.09B	1.14B	1.2B	1.27B	1.37B
(Gain) Loss From Sale Of Asset	-78M	22M	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-250M	1M	59M	79M	-139M
Asset Writedown & Restructuring Costs	370M	132M	58M	386M	46M
Stock-Based Compensation (CF)	194M	220M	233M	266M	299M
Other Operating Activities, Total	-149M	322M	135M	43M	308M
Change In Accounts Receivable	-279M	-220M	-238M	-351M	-269M
Change In Inventories	-346M	-321M	-660M	-228M	-188M
Change In Accounts Payable	408M	-255M	118M	243M	296M
Change in Other Net Operating Assets	-134M	-209M	10M	-126M	-85M
Cash from Operations	1.87B	1.53B	2.5B	3.44B	4.53B
Capital Expenditure	-554M	-588M	-711M	-790M	-876M
Sale of Property, Plant, and Equipment	14M	12M	4M	3M	-
Cash Acquisitions	-2.26B	-1.54B	-1.81B	-4.64B	-1.59B
Divestitures	826M	5M	-	-	-
Sale (Purchase) of Intangible assets	82M	70M	30M	20M	-
Investment in Marketable and Equity Securities, Total	279M	-24M	-89M	-280M	-254M
Other Investing Activities, Total	14M	56M	3M	-	83M
Cash from Investing	-1.6B	-2.01B	-2.57B	-5.69B	-2.64B
Short Term Debt Issued, Total	-	-	-	211M	-
Long-Term Debt Issued, Total	-	3.27B	-	2.14B	1.56B
Total Debt Issued	-	3.27B	-	2.36B	1.56B
Short Term Debt Repaid, Total	-	-251M	-4M	-504M	-1.79B
Long-Term Debt Repaid, Total	-	-3.18B	-	-25M	-258M
Total Debt Repaid	-	-3.44B	-4M	-529M	-2.05B
Issuance of Common Stock	110M	136M	182M	230M	282M
Repurchase of Common Stock	-	-	-	-	-
Issuance of Preferred Stock	-	-	-	-	-
Preferred Dividends Paid	-55M	-55M	-28M	-	-
Common & Preferred Stock Dividends Paid	-55M	-55M	-28M	-	-
Other Financing Activities, Total	-150M	-464M	-145M	-243M	-186M
Cash from Financing	-95M	-548M	5M	1.81B	-395M
Foreign Exchange Rate Adjustments	-6M	-9M	-4M	-11M	42M
Miscellaneous Cash Flow Adjustments	1M	-	-	-1M	-
Net Change in Cash	173M	-1.04B	-70M	-450M	1.54B
Supplemental Items
Cash Interest Paid	338M	450M	259M	250M	319M
Cash Income Tax Paid (Refund)	302M	662M	512M	656M	561M
Levered Free Cash Flow	2.77B	1.15B	1.88B	1.81B	3.24B
Unlevered Free Cash Flow	2.98B	1.45B	2.05B	2B	3.46B
Change In Net Working Capital	-912M	660M	213M	643M	-187M
Net Debt Issued / Repaid	-	-165M	-4M	1.83B	-491M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.99	3.93	4.47	5.03	5.98
Return on Total Capital	4.92	4.79	5.39	6.02	7.12
Return On Equity %	6.52	4.08	8.58	8.89	12.45
Return on Common Equity	6.17	3.75	8.52	9.03	12.6
Margin Analysis
Gross Profit Margin %	69.32	68.44	69.16	68.41	68.78
SG&A Margin	36.06	35.64	36.45	35.73	34.31
EBITDA Margin %	26.09	24.99	25.37	25.5	26.6
EBITA Margin %	23.13	22.36	22.79	23.04	24.25
EBIT Margin %	16.9	16.03	16.97	17.93	19.78
Income From Continuing Operations Margin %	8.76	5.5	11.17	11.02	14.41
Net Income Margin %	8.76	5.5	11.18	11.07	14.44
Net Avail. For Common Margin %	8.29	5.06	11.03	11.06	14.44
Normalized Net Income Margin	8.61	7.53	9.3	10.34	11.25
Levered Free Cash Flow Margin	23.3	9.11	13.2	10.79	16.15
Unlevered Free Cash Flow Margin	25.09	11.42	14.37	11.93	17.24
Asset Turnover
Asset Turnover	0.38	0.39	0.42	0.45	0.48
Fixed Assets Turnover	4.55	4.6	4.65	4.76	4.87
Receivables Turnover (Average Receivables)	7.19	6.77	6.78	7	7.32
Inventory Turnover (Average Inventory)	2.46	2.3	2.02	2	2.18
Short Term Liquidity
Current Ratio	1.48	1.51	1.32	1.08	1.62
Quick Ratio	0.87	0.76	0.63	0.46	0.9
Operating Cash Flow to Current Liabilities	0.44	0.4	0.51	0.54	0.83
Days Sales Outstanding (Average Receivables)	50.8	53.94	53.8	52.3	49.86
Days Outstanding Inventory (Average Inventory)	148.17	158.52	180.84	183.14	167.53
Average Days Payable Outstanding	61.07	70.94	65.74	61.98	60
Cash Conversion Cycle (Average Days)	137.9	141.51	168.9	173.46	157.39
Long Term Solvency
Total Debt/Equity	57.3	53.17	48.99	51.03	48.92
Total Debt / Total Capital	36.43	34.71	32.88	33.79	32.85
LT Debt/Equity	55.31	52.71	45.88	42.58	47.33
Long-Term Debt / Total Capital	35.16	34.41	30.8	28.19	31.78
Total Liabilities / Total Assets	48.43	45.88	44.42	44.15	43.97
EBIT / Interest Expense	5.89	4.33	9.12	9.84	11.38
EBITDA / Interest Expense	9.36	6.94	14	14.32	15.63
(EBITDA - Capex) / Interest Expense	7.74	5.69	11.31	11.73	13.12
Total Debt / EBITDA	2.98	2.87	2.58	2.57	2.19
Net Debt / EBITDA	2.38	2.58	2.35	2.48	1.83
Total Debt / (EBITDA - Capex)	3.61	3.5	3.19	3.14	2.61
Net Debt / (EBITDA - Capex)	2.88	3.15	2.9	3.02	2.18
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	19.92	6.68	12.29	17.61	19.87
Gross Profit, 1 Yr. Growth %	21.32	6.78	13.48	16.33	20.51
EBITDA, 1 Yr. Growth %	37.74	8.64	14.01	18.21	25.01
EBITA, 1 Yr. Growth %	43.38	10.57	14.42	18.89	26.18
EBIT, 1 Yr. Growth %	77.94	11.46	18.89	24.2	32.28
Earnings From Cont. Operations, 1 Yr. Growth %	-1.37K	-32.95	127.94	15.95	56.75
Net Income, 1 Yr. Growth %	-1.37K	-32.95	128.08	16.38	56.4
Normalized Net Income, 1 Yr. Growth %	119.87	5.16	38.65	30.72	30.5
Diluted EPS Before Extra, 1 Yr. Growth %	-950.03	-34.96	138.42	16.82	55.2
Accounts Receivable, 1 Yr. Growth %	16.13	10.8	13.1	14.81	14.39
Inventory, 1 Yr. Growth %	19.17	15.96	33.05	13.12	4.73
Net Property, Plant and Equip., 1 Yr. Growth %	5.7	5.4	16.45	13.49	20.25
Total Assets, 1 Yr. Growth %	4.72	0.74	8.21	12.12	10.86
Tangible Book Value, 1 Yr. Growth %	110.66	-17.8	-13.53	80.78	-46.68
Common Equity, 1 Yr. Growth %	8.46	5.72	9.73	12.9	11.31
Cash From Operations, 1 Yr. Growth %	24.01	-18.4	64.02	37.24	31.99
Capital Expenditures, 1 Yr. Growth %	47.34	6.14	20.92	11.11	10.89
Levered Free Cash Flow, 1 Yr. Growth %	126.82	-56.48	62.79	-3.85	81.34
Unlevered Free Cash Flow, 1 Yr. Growth %	106.18	-49.47	41.21	-2.32	74.9
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.23	13.11	9.45	14.91	18.73
Gross Profit, 2 Yr. CAGR %	3.91	14.06	10.08	14.89	18.4
EBITDA, 2 Yr. CAGR %	4.47	23.58	11.29	16.09	21.56
EBITA, 2 Yr. CAGR %	4.26	27.63	12.48	16.63	22.48
EBIT, 2 Yr. CAGR %	4.75	46.13	15.11	21.52	28.18
Earnings From Cont. Operations, 2 Yr. CAGR %	-52.94	191.76	23.63	62.63	34.78
Net Income, 2 Yr. CAGR %	-52.94	191.76	23.66	62.98	34.88
Normalized Net Income, 2 Yr. CAGR %	9.99	64.02	20.75	34.66	30.59
Diluted EPS Before Extra, 2 Yr. CAGR %	-54.48	135.13	24.53	66.89	34.65
Accounts Receivable, 2 Yr. CAGR %	-1.38	13.43	11.94	13.95	14.6
Inventory, 2 Yr. CAGR %	0.98	17.56	24.21	22.68	8.85
Net Property, Plant and Equip., 2 Yr. CAGR %	5.48	5.55	10.79	14.96	16.82
Total Assets, 2 Yr. CAGR %	2.69	2.71	4.41	10.15	11.49
Tangible Book Value, 2 Yr. CAGR %	-40.47	31.59	-15.69	23.37	-1.82
Common Equity, 2 Yr. CAGR %	9.44	7.08	7.7	11.3	12.11
Cash From Operations, 2 Yr. CAGR %	0.92	0.6	15.69	50.03	34.59
Capital Expenditures, 2 Yr. CAGR %	9.62	25.05	13.29	15.91	11
Levered Free Cash Flow, 2 Yr. CAGR %	40.56	1.98	-15.83	25.11	32.37
Unlevered Free Cash Flow, 2 Yr. CAGR %	32.56	4.13	-15.53	17.45	31.02
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	6.57	5.71	12.83	12.1	16.54
Gross Profit, 3 Yr. CAGR %	5.63	4.38	13.87	12.12	16.74
EBITDA, 3 Yr. CAGR %	5.82	3.7	20.3	13.55	18.99
EBITA, 3 Yr. CAGR %	5.79	3.88	23.07	14.58	19.73
EBIT, 3 Yr. CAGR %	5.23	3.55	36.42	18.07	25
Earnings From Cont. Operations, 3 Yr. CAGR %	-14.59	-47.04	168.71	21.04	60.61
Net Income, 3 Yr. CAGR %	-14.59	-47.04	168.77	21.21	60.72
Normalized Net Income, 3 Yr. CAGR %	3.32	4.11	55.08	24.01	33.24
Diluted EPS Before Extra, 3 Yr. CAGR %	-16.61	-48.73	136.22	21.9	62.9
Accounts Receivable, 3 Yr. CAGR %	3.41	2.52	13.32	12.89	14.1
Inventory, 3 Yr. CAGR %	11.35	5.74	22.51	20.4	16.38
Net Property, Plant and Equip., 3 Yr. CAGR %	14.67	5.45	9.07	11.68	16.7
Total Assets, 3 Yr. CAGR %	15.35	2.03	4.51	6.92	10.39
Tangible Book Value, 3 Yr. CAGR %	-33.95	-33.71	14.4	7.75	-6.72
Common Equity, 3 Yr. CAGR %	23.96	8.19	7.95	9.41	11.31
Cash From Operations, 3 Yr. CAGR %	82.04	-5.98	18.4	22.47	43.76
Capital Expenditures, 3 Yr. CAGR %	20.58	8.45	23.66	12.56	14.21
Levered Free Cash Flow, 3 Yr. CAGR %	73.22	-6.25	19.19	-12.01	41.06
Unlevered Free Cash Flow, 3 Yr. CAGR %	63.41	-5.15	15.26	-11.34	33.67
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	7.23	6.99	7.71	9.3	15.16
Gross Profit, 5 Yr. CAGR %	6.77	6.14	7.09	8.46	15.66
EBITDA, 5 Yr. CAGR %	7.06	5.34	6.65	8.49	20.81
EBITA, 5 Yr. CAGR %	7.27	5.56	6.91	8.8	22.83
EBIT, 5 Yr. CAGR %	7.63	4.92	6.99	10.39	33.06
Earnings From Cont. Operations, 5 Yr. CAGR %	24.57	46.34	-0.98	-17.05	103.93
Net Income, 5 Yr. CAGR %	24.57	46.34	-0.96	-16.98	104.01
Normalized Net Income, 5 Yr. CAGR %	7.48	2.69	7.37	15.4	44.79
Diluted EPS Before Extra, 5 Yr. CAGR %	22.51	42.68	-2.1	-17.8	88.66
Accounts Receivable, 5 Yr. CAGR %	3.85	4.94	6.74	6.95	13.83
Inventory, 5 Yr. CAGR %	11.01	11.61	16.33	12.22	16.85
Net Property, Plant and Equip., 5 Yr. CAGR %	10.51	10.79	13.1	9.16	12.11
Total Assets, 5 Yr. CAGR %	12.24	11.26	10.84	5.21	7.25
Tangible Book Value, 5 Yr. CAGR %	-22.77	-25.73	-27.18	-15.01	7.04
Common Equity, 5 Yr. CAGR %	19.81	20.17	17.18	9.42	9.6
Cash From Operations, 5 Yr. CAGR %	9.61	1.36	51.85	13.35	24.63
Capital Expenditures, 5 Yr. CAGR %	8.06	13.01	17.61	11.37	18.43
Levered Free Cash Flow, 5 Yr. CAGR %	2.2	-1.54	28.68	5.22	23.9
Unlevered Free Cash Flow, 5 Yr. CAGR %	2.55	0.81	24.51	3.32	20.96